Usana Health Sciences (USNA) Gross Margin (2010 - 2026)

Usana Health Sciences (USNA) has reported Gross Margin for 17 consecutive years, with 78.35% the latest figure, recorded in Q3 2026.

• On a quarterly basis, Gross Margin fell 37.0% year-over-year to 78.35% in Q3 2026; TTM through Jul 2026 was 77.45%, a 249.0% decrease from a year earlier, with the FY2026 full-year figure at 78.29%, down 284.0% from the prior year.
• Gross Margin was 78.35% for Q3 2026 at Usana Health Sciences, up from 76.25% in the prior quarter.
• Over five years, Gross Margin peaked at 81.95% in Q4 2024 and troughed at 76.25% in Q2 2026.
• A 5-year average of 79.93% and a median of 80.39% in 2024 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin soared 123 bps in 2023 and sank 379 bps in 2026, its largest moves.
• Over 5 years, Gross Margin stood at 79.63% in 2022, then increased by 2 bps to 80.86% in 2023, then climbed by 1 bps to 81.95% in 2024, then decreased by 6 bps to 77.15% in 2025, then grew by 2 bps to 78.35% in 2026.
• The last three Gross Margin figures came in at 78.35% (Q3 2026), 76.25% (Q2 2026), and 78.16% (Q1 2026), per Business Quant data.